PTCT — PTC Therapeutics Balance Sheet
0.000.00%
- $5.24bn
- $5.65bn
- $806.78m
- 89
- 92
- 93
- 100
Annual balance sheet for PTC Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
| 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,104 | 773 | 411 | 877 | 1,140 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 69.9 | 110 | 156 | 161 | 159 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 1,232 | 954 | 694 | 1,219 | 1,366 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 118 | 130 | 175 | 179 | 118 | 
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,208 | 1,938 | 1,706 | 1,896 | 1,705 | 
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 277 | 509 | 406 | 603 | 581 | 
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,726 | 1,937 | 2,053 | 2,714 | 2,803 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 482 | 1.44 | -347 | -819 | -1,098 | 
| Total Liabilities & Shareholders' Equity | 2,208 | 1,938 | 1,706 | 1,896 | 1,705 | 
| Total Common Shares Outstanding |